JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

Home・Akcijų sąrašas・Kala Pharmaceuticals Inc

Kala Pharmaceuticals Inc

Uždarymo kaina

0.79 5.33

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

0.72

Max

0.79

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+957.69% upside

Dividendai
By Dow Jones
Kitas uždarbis	2025-11-10

Kala Pharmaceuticals Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-11-01 12:56; UTC

Uždarbis

Berkshire's Quarterly Earnings Rise After Insurance Results Improve -- WSJ

2025-11-01 12:56; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

2025-11-01 12:20; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

2025-11-01 12:19; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

2025-11-01 08:20; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2025-11-01 08:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-11-01 05:00; UTC

Uždarbis

Įsigijimai, susijungimai, perėmimai

Berkshire Hathaway Probably Had a Stellar Quarter. Stock Buybacks Are a Wild Card. -- Barrons.com

2025-11-01 00:10; UTC

Uždarbis

Trouble on The Strip -- Barrons.com

2025-10-31 23:09; UTC

Uždarbis

Review & Preview: October Surprise -- Barrons.com

2025-10-31 22:44; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ

2025-10-31 21:25; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Pfizer Says Novo Nordisk's Metsera Bid Won't Pass Antitrust Laws -- Market Talk

2025-10-31 21:20; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- Update

2025-10-31 21:12; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer Sues Metsera, Novo Nordisk, Claiming Novo Nordisk Takeover Offer Isn't Superior -- WSJ

2025-10-31 21:12; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ

2025-10-31 21:12; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer Seeks Order Blocking Metsera From Terminating Its Merger Deal With Pfizer -- WSJ

2025-10-31 20:51; UTC

Įsigijimai, susijungimai, perėmimai

Another Rare-Earth Stock Jumps on Government Deal -- Barrons.com

2025-10-31 20:50; UTC

Rinkos pokalbiai

Financial Services Roundup: Market Talk

2025-10-31 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-10-31 20:50; UTC

Rinkos pokalbiai

Uždarbis

Auto & Transport Roundup: Market Talk

2025-10-31 20:46; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer: Files Lawsuit Against Metsera and Its Directors and Novo Nordisk for Breach of Merger Agreement

2025-10-31 20:22; UTC

Uždarbis

Amazon Stock Hits New Record. What Was So Good in Its Earnings Report. -- Barrons.com

2025-10-31 20:02; UTC

Uždarbis

Meta Faces a Sudden Reckoning. How Big Tech Earnings Are Reshaping the AI Race. -- Barrons.com

2025-10-31 19:55; UTC

Rinkos pokalbiai

Crude Futures Fall for Third Straight Month -- Market Talk

2025-10-31 19:54; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer: FTC Granted Early Termination of Waiting Period >PFE

2025-10-31 19:54; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer: Receives Early Clearance From FTC for Metsera Acquisition

2025-10-31 19:26; UTC

Rinkos pokalbiai

U.S. Natural Gas Rises on Winter Outlook, Strong LNG -- Market Talk

2025-10-31 18:30; UTC

Uždarbis

These Stocks Are Moving the Most Today: Amazon, Nvidia, Apple, Netflix, Exxon, DexCom, Coinbase, Reddit, Newell Brands, and More -- Barrons.com

2025-10-31 18:23; UTC

Rinkos pokalbiai

Gold Edges Lower for the Day, Closes October Positive -- Market Talk

2025-10-31 18:09; UTC

Uždarbis

Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com

2025-10-31 18:08; UTC

Uždarbis

Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Kala Pharmaceuticals Inc Prognozė

Kainos tikslas

By TipRanks

957.69% į viršų

12 mėnesių prognozė

Vidutinis 8.25 USD 957.69%

Aukščiausias 15 USD

Žemiausias 1.5 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Kala Pharmaceuticals Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

3 ratings

Pirkti

Laikyti

Parduoti

Remiantis 3 analitikų, pateikusių Kala Pharmaceuticals Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Finansinės naujienos

Apie bendrovę Kala Pharmaceuticals Inc

Kala Pharmaceuticals Inc

Kitos sektoriaus akcijos

JNJ

Johnson and Johnson

188.98

↓-0.04%

ABT

Abbott Laboratories

123.58

↓-0.84%

TMO

Thermo Fisher Scientific Inc

568.01

↑ +2.1%

ISRG

Intuitive Surgical Inc

534.39

↑ +0.84%

DHR

Danaher Corp

215.62

↑ +0.34%

Kala Pharmaceuticals Inc

Apžvalga

Akcijų kainos pasikeitimas

Pagrindiniai rodikliai

Rekomendacijos

Dividendai

Kala Pharmaceuticals Inc Grafikas

Susijusios naujienos

Akcijų palyginimas

Kala Pharmaceuticals Inc Prognozė

Kainos tikslas

Bendras įvertinimas

Finansinės naujienos

Apie bendrovę Kala Pharmaceuticals Inc

Kitos sektoriaus akcijos